The Medicines Company - Company & Market Research Reports

The Medicines Company aims to be a leader in the areas of serious infectious disease care, acute cardiovascular care, and surgery and perioperative care. Its marketed products include Angiomax, an anticoagulant used during coronary angioplasties; Cleviprex, an intravenous small molecule calcium channel blocker for blood pressure reduction; and Ionsys for the short-term management of acute postoperative pain. The Medicines Company was founded in 1996 and is based in Parsippany, New Jersey.

From
From
From
From
From
From
Bacterial Pneumonia - Pipeline Insight, 2018 - Product Thumbnail Image

Bacterial Pneumonia - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
From
From
From
From
From
From
Loading Indicator
adroll